
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9910241
[patent_doc_number] => 20150065443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'EMBELIN-BASED DELIVERY SYSTEM FOR WATER-INSOLUBLE ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/391001
[patent_app_country] => US
[patent_app_date] => 2013-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15950
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391001
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/391001 | EMBELIN-BASED DELIVERY SYSTEM FOR WATER-INSOLUBLE ACTIVE AGENTS | Apr 3, 2013 | Abandoned |
Array
(
[id] => 8951432
[patent_doc_number] => 20130197213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Low Temperature Chlorination of Carbohydrates'
[patent_app_type] => utility
[patent_app_number] => 13/826493
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6154
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826493
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/826493 | Low temperature, vacuum assisted chlorination of sucrose-6-esters free of overchlorinated by-products as intermediates for the production of the artificial sweetener, sucralose | Mar 13, 2013 | Issued |
Array
(
[id] => 8940472
[patent_doc_number] => 20130190269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'POLYSACCHARIDES COMPOSITIONS COMPRISING FUCANS AND GALACTANS AND THEIR USE TO REDUCE EXTRAVASATION AND INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 13/796457
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19521
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13796457
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/796457 | POLYSACCHARIDES COMPOSITIONS COMPRISING FUCANS AND GALACTANS AND THEIR USE TO REDUCE EXTRAVASATION AND INFLAMMATION | Mar 11, 2013 | Abandoned |
Array
(
[id] => 9839557
[patent_doc_number] => 20150031639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'NEW C-GLYCOSYLPOLYPHENOL ANTIDIABETIC AGENTS, EFFECT ON GLUCOSE TOLERANCE AND INTERACTION WITH BETA-AMYLOID. THERAPEUTIC APPLICATIONS OF THE SYNTHESIZED AGENT(S) AND OF GENISTA TENERA ETHYL ACETATE EXTRACTS CONTAINING SOME OF THOSE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/384145
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10940
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384145
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/384145 | C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents | Mar 10, 2013 | Issued |
Array
(
[id] => 9041087
[patent_doc_number] => 20130243725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => '2\'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/793557
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18493
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13793557
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/793557 | 2′-substituted carba-nucleoside analogs for antiviral treatment | Mar 10, 2013 | Issued |
Array
(
[id] => 9069322
[patent_doc_number] => 20130261077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/787418
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 77371
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13787418
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/787418 | MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | Mar 5, 2013 | Abandoned |
Array
(
[id] => 9042614
[patent_doc_number] => 20130245252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'SIMULTANEOUS HYDROLYSIS AND HYDROGENATION OF CELLULOSE'
[patent_app_type] => utility
[patent_app_number] => 13/783516
[patent_app_country] => US
[patent_app_date] => 2013-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4114
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13783516
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/783516 | SIMULTANEOUS HYDROLYSIS AND HYDROGENATION OF CELLULOSE | Mar 3, 2013 | Abandoned |
Array
(
[id] => 8951162
[patent_doc_number] => 20130196943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'NOVEL CHONDROITIN SULFATE HAVING DECREASED MOLECULAR WEIGHT AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/782165
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7057
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782165
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/782165 | Chondroitin sulfate having decreased molecular weight and use thereof | Feb 28, 2013 | Issued |
Array
(
[id] => 9004391
[patent_doc_number] => 20130225516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'TOPICAL COMPOSITIONS COMPRISING FIPRONIL AND PERMETHRIN AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/774159
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22315
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13774159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/774159 | Topical compositions comprising fipronil and permethrin and methods of use | Feb 21, 2013 | Issued |
Array
(
[id] => 9004393
[patent_doc_number] => 20130225518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/773686
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 46420
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13773686
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/773686 | Method for treating advanced non-small cell lung cancer (NSCLC) by administering a combination of a TOR kinase inhibitor and azacitidine or erlotinib | Feb 21, 2013 | Issued |
Array
(
[id] => 11813869
[patent_doc_number] => 09717801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Glycogen-based cationic polymers'
[patent_app_type] => utility
[patent_app_number] => 14/376299
[patent_app_country] => US
[patent_app_date] => 2013-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 16596
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376299
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376299 | Glycogen-based cationic polymers | Feb 20, 2013 | Issued |
Array
(
[id] => 9858677
[patent_doc_number] => 20150038694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'GLUCOSE DERIVATIVES BOUND TO ARSENIC FOR USE IN THE TREATMENT OF TUMOUR'
[patent_app_type] => utility
[patent_app_number] => 14/374294
[patent_app_country] => US
[patent_app_date] => 2013-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3236
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374294
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/374294 | GLUCOSE DERIVATIVES BOUND TO ARSENIC FOR USE IN THE TREATMENT OF TUMOUR | Feb 18, 2013 | Abandoned |
Array
(
[id] => 9799556
[patent_doc_number] => 20150011501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'PARTIALLY DEPOLYMERIZED GLYCOSAMINOGLYCAN SILVER AND GOLD SALTS'
[patent_app_type] => utility
[patent_app_number] => 14/375306
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8970
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375306
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/375306 | PARTIALLY DEPOLYMERIZED GLYCOSAMINOGLYCAN SILVER AND GOLD SALTS | Feb 14, 2013 | Abandoned |
Array
(
[id] => 11634020
[patent_doc_number] => 09655975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Prodrug using nitroimidazole'
[patent_app_type] => utility
[patent_app_number] => 14/376459
[patent_app_country] => US
[patent_app_date] => 2013-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 6032
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376459
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376459 | Prodrug using nitroimidazole | Feb 12, 2013 | Issued |
Array
(
[id] => 10251642
[patent_doc_number] => 20150136638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'METHOD FOR PREPARING A SYRUPY PRODUCT COMPRISING VITAMINS'
[patent_app_type] => utility
[patent_app_number] => 14/406530
[patent_app_country] => US
[patent_app_date] => 2013-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6673
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406530
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406530 | METHOD FOR PREPARING A SYRUPY PRODUCT COMPRISING VITAMINS | Jan 28, 2013 | Abandoned |
Array
(
[id] => 12198598
[patent_doc_number] => 09901648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'Stabilization of biomolecules using sugar polymers'
[patent_app_type] => utility
[patent_app_number] => 14/374388
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 35
[patent_no_of_words] => 27034
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374388
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/374388 | Stabilization of biomolecules using sugar polymers | Jan 24, 2013 | Issued |
Array
(
[id] => 9616776
[patent_doc_number] => 20140206634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'Natural Composition to Decrease Effects of a High Fat Diet'
[patent_app_type] => utility
[patent_app_number] => 13/746630
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8675
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746630
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/746630 | Natural composition to decrease effects of a high fat diet | Jan 21, 2013 | Issued |
Array
(
[id] => 9281334
[patent_doc_number] => 20140031303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'Bioactive hybrid of ionic/polyhydroxyl, lipophilic and covalently reactive moieties and method of use'
[patent_app_type] => utility
[patent_app_number] => 13/741281
[patent_app_country] => US
[patent_app_date] => 2013-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4167
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13741281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/741281 | Bioactive hybrid of ionic/polyhydroxyl, lipophilic and covalently reactive moieties and method of use | Jan 13, 2013 | Abandoned |
Array
(
[id] => 8892217
[patent_doc_number] => 20130165401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'NUCLEOSIDE PHOSPHORAMIDATES'
[patent_app_type] => utility
[patent_app_number] => 13/732725
[patent_app_country] => US
[patent_app_date] => 2013-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 33474
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13732725
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/732725 | Nucleoside phosphoramidates | Jan 1, 2013 | Issued |
Array
(
[id] => 9786299
[patent_doc_number] => 20140303118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Synergistic Anti-Diabetic Compositions'
[patent_app_type] => utility
[patent_app_number] => 14/359759
[patent_app_country] => US
[patent_app_date] => 2012-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14416
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359759
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/359759 | Synergistic anti-diabetic compositions | Nov 22, 2012 | Issued |